Dinutuximab Beta

ATC L01FX06 · 7 markets · 8 records

Dinutuximab Beta 7 markets · 8 records Forms

AU 2 records · 2 strengths

4.5 mg/mLliquidQARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名QARZIBA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 1 records · 1 strengths

20 mg/4.5 mLinjectionQarziba 20mg/4.5ml concentrate for solution for infusion vials

ES 1 records · 1 strengths

4.5 mg/1 mLinjectionQARZIBA also in FR

TW 1 records · 1 strengths

4.5 mginjectionQarziba 4.5 mg/mL concentrate for solution for infusion+1寬利安濃縮輸注液

HK 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名QARZIBA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/4.5ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名QARZIBA ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 strengths

4.5 mg/1 mLinjectionQARZIBA 4,5 mg/ml, solution à diluer pour perfusion also in ES

Side-by-side table

Strength / form / release	GB	AU	ES	TW	HK	EU	FR
4.5 mg/1 mL injection	not recorded	not recorded	QARZIBA	not recorded	not recorded	not recorded	QARZIBA 4,5 mg/ml, solution à diluer pour perfusion
4.5 mg injection	not recorded	not recorded	not recorded	Qarziba 4.5 mg/mL concentrate for solution for infusion 寬利安濃縮輸注液	not recorded	not recorded	not recorded
4.5 mg/mL liquid	not recorded	QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg/4.5 mL injection	Qarziba 20mg/4.5ml concentrate for solution for infusion vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	QARZIBA	not recorded	not recorded	QARZIBA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/4.5ML	QARZIBA	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in GB and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en GB que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 GB 有记录（未在本表显示）。另有 1 個規格/劑型僅在 GB 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.